Tears can convey happiness, sorrow, relief, or even annoyance; they are a universal language. The Crying Disease, sometimes called Pseudobulbar Affect (PBA), causes uncontrollable and unexpected tears in its victims. The disorder frequently manifests itself independently of a person’s true feelings and generates unexpected bursts of sobbing or, in certain situations, laughter. For those impacted, everyday life can turn into a series of uncomfortable, unplanned incidents that complicate even the most basic social situations.
The Crying Disease: Causes, Symptoms, and Treatment
Feature | Details |
---|---|
Medical Term | Pseudobulbar Affect (PBA) |
Primary Symptoms | Uncontrollable episodes of crying or laughing, often mismatched with emotions |
Common Causes | Stroke, ALS, multiple sclerosis, traumatic brain injury, dementia |
Diagnosis | Often confused with depression or anxiety disorders |
Impact on Life | Social isolation, emotional distress, embarrassment |
Treatment Options | Medications (e.g., Nuedexta), cognitive behavioral therapy, lifestyle adjustments |
Reference | Mayo Clinic |
PBA takes over an individual’s capacity to regulate their emotional expressions by intervening in areas of the brain involved in emotional regulation. A cheerful talk may cause someone to cry, or they may laugh uncontrollably at an unsuitable time. PBA only affects the outward manifestation of emotions, as opposed to mood disorders, which alter emotions themselves. This results in a frustrating discrepancy between an individual’s sentiments and their reactions.

Patients who suffer from neurological conditions like ALS, Parkinson’s disease, multiple sclerosis, and Alzheimer’s disease are frequently affected by the condition. The ability to control emotional expression is hampered when damage is sustained to the brainstem and cerebellum, two important areas involved in processing emotions, according to studies. What was the outcome? episodes where the affected individual and those around them may experience distress.
For many years, PBA was misinterpreted. Some thought it was just a sign of despair, while others wrote it off as being too sensitive. Rather of being identified with a neurological illness, many patients were left to feel they were emotionally unstable. However, people who have endured the stigma of misdiagnosis now have hope because to advancements in medical knowledge and therapeutic alternatives.
Nuedexta, an FDA-approved medication that controls emotional outbursts, is one of the most unusually successful therapies for PBA. Patients have been able to regain control over their emotional reactions by using the medicine to target brain circuits related to emotional control, which has decreased the frequency and severity of episodes. Furthermore, several antidepressants—SSRIs in particular—have been used to treat symptoms, with differing degrees of efficacy.
Patients have also found that psychological therapy is especially helpful in identifying their triggers. Cognitive behavioral therapy (CBT) helps people to predict their emotional outbursts and learn how to control them before they become out of control. The illness cannot be cured, however therapy helps sufferers deal with the social difficulties that arise from unplanned emotional outbursts.
Public discourse about PBA has been aided by high-profile cases. The renowned comedian and actor Robin Williams was discovered to have had undetected Lewy body dementia, which is known to cause PBA, after his death. Similar to this, Tim Green, a former NFL player who was diagnosed with ALS, has discussed the psychological effects of having uncontrollable bursts of laughter and tears. Because of these incidents, stigma has decreased and more people are seeking medical attention rather than suffering in silence.
According to recent accounts, people in the Democratic Republic of the Congo have been suffering from an unexplained ailment that causes protracted, uncontrollable crying before leading to deadly complications. The outbreak, which has been dubbed the “Crying Disease,” has perplexed scientists. The condition’s similarity to PBA has prompted inquiries about whether a neurological element is involved, even if preliminary research point to a potential viral infection. The medical knowledge of emotional regulation disorders may advance if the outbreak is shown to be caused by viral-induced neurological damage or inflammation of the brain.
The increased understanding of PBA is indicative of a more general change in the research and management of neurological conditions. Emotional expression disorders were formerly frequently written off as psychological rather than physical. More focused treatments are now possible as a result of researchers’ growing understanding of the intricate brain circuits governing emotional reactions thanks to developments in neuroscience and imaging technologies.
In order to reestablish appropriate emotional control, researchers are currently investigating the possibilities of gene editing, deep brain stimulation, and stem cell therapy. Although still in the experimental stage, these medicines hold great promise for those with diseases like PBA.
But awareness is still the largest obstacle for many patients. Even though PBA is a recognized medical disorder, many people struggle without receiving the right therapy since it is still commonly misdiagnosed. To make sure that individuals impacted get the assistance and medical attention they require, it will be essential to boost research initiatives, enhance neurological tests, and raise public awareness.
In addition, employers, families, and caretakers assist people with PBA in navigating their everyday lives. PBA episodes are frequently angrily divorced from a person’s true emotions, in contrast to disorders like melancholy or anxiety, where mood swings are profoundly recognized. Providing the appropriate kind of support requires an understanding of this distinction. In order to lessen the psychological and social costs related to PBA, open communication, community resources, and continuous medical advancements will be essential.